The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118552725 11855272 5 F 20131208 20160907 20151221 20160914 EXP PHHY2013AT171568 NOVARTIS 53.00 YR M Y 98.00000 KG 20160914 MD AT AT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118552725 11855272 1 PS VOTRIENT PAZOPANIB HYDROCHLORIDE 1 Unknown 800 MG, QD 175200 MG 22465 800 MG TABLET QD
118552725 11855272 2 SS VOTRIENT PAZOPANIB HYDROCHLORIDE 1 Unknown 400 MG, QD 175200 MG 22465 400 MG TABLET QD
118552725 11855272 3 SS VOTRIENT PAZOPANIB HYDROCHLORIDE 1 Unknown 400 MG, QD 175200 MG 22465 400 MG TABLET QD
118552725 11855272 4 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD Y 0 10 MG QD
118552725 11855272 5 C NEXAVAR SORAFENIB 1 Unknown UNK 0
118552725 11855272 6 C NEXAVAR SORAFENIB 1 ALTERNATIVELY AT 400/800 MG DOSE 0
118552725 11855272 7 C PANTOLOC//PANTOPRAZOLE SODIUM SESQUIHYDRATE PANTOPRAZOLE SODIUM 1 Oral 40 MG, QD U 0 40 MG QD
118552725 11855272 8 C LOVENOX ENOXAPARIN SODIUM 1 Subcutaneous 80 MG, QD U 0 80 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118552725 11855272 1 Renal cell carcinoma
118552725 11855272 4 Renal cell carcinoma
118552725 11855272 5 Product used for unknown indication
118552725 11855272 7 Product used for unknown indication
118552725 11855272 8 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
118552725 11855272 HO
118552725 11855272 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118552725 11855272 Anal fistula
118552725 11855272 Body temperature increased
118552725 11855272 Breath sounds
118552725 11855272 Candida infection
118552725 11855272 Cheilitis
118552725 11855272 Cholelithiasis
118552725 11855272 Diarrhoea
118552725 11855272 Dyspnoea
118552725 11855272 Hilar lymphadenopathy
118552725 11855272 Laryngeal oedema
118552725 11855272 Laryngitis
118552725 11855272 Lip ulceration
118552725 11855272 Malignant neoplasm progression
118552725 11855272 Mucosal inflammation
118552725 11855272 Necrotising fasciitis
118552725 11855272 Neutropenia
118552725 11855272 Night sweats
118552725 11855272 Oedema mucosal
118552725 11855272 Pain
118552725 11855272 Pneumonia
118552725 11855272 Productive cough
118552725 11855272 Pubis fracture
118552725 11855272 Renal failure
118552725 11855272 Stomatitis
118552725 11855272 Tongue ulceration

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118552725 11855272 1 20130324 20131028 0
118552725 11855272 2 201311 20131212 0
118552725 11855272 3 20140106 20140218 0
118552725 11855272 4 20141216 0
118552725 11855272 5 201402 0
118552725 11855272 7 20131213 0
118552725 11855272 8 20131213 0